Abstracts

Share Your Cutting-Edge Research as a Poster at SAWC Spring | WHS 2027

The Symposium on Advanced Wound Care (SAWC) Spring | WHS 2027 invites you to submit an abstract for consideration to be presented as a poster at the meeting in Philadelphia, Pennsylvania, April 28–May 2, 2027. Posters will be on display during all poster hall hours and on multimedia screens located in the conference space. ePosters will also be available to view in the mobile app.

SAWC Spring | WHS 2027 Abstract Overview

Abstracts are brief summaries of the overall goal and the specific ideas or concepts that will be presented, including outcomes and implications for practice. Abstracts should be 250–350 words only, and should be divided into the following sections: introduction, methods, results, and discussion. View an in-depth overview of the Abstract Submission Guidelines here.

Key Dates* for Abstract Submissions

Abstract Submission Site Opens: Wednesday, September 16, 2026
Abstract Submission Site Closes: Monday, January 11, 2027, 12:00 PM ET
Notification of Acceptance or Rejection: Wednesday, March 3, 2027
Registration and Intent to Present Due: Wednesday, March 17, 2027
PDF Posters Due: Wednesday, March 31, 2027

*Deadlines are subject to change.

Abstracts submitted by January 11, 2027, may be eligible for the following benefits and/or awards:

Poster Hall Poster Display (Printed Poster)
ePoster Display (Digital Poster PDF)
First-to-Podium Abstract Presentations
Marie Brown Etris Oral Abstract Presentations
RAPID-FIRE Poster Talks
Publishing opportunities in Wounds (ISSN 1943-2704), the official journal of SAWC
Tuition Support ($50 off Registration Fee)
Highest Scoring Abstract Awards (by Submission Category)
Young Investigator Award

Abstract Presentation Categories

1. First-to-Podium Presentation Only

The First-to-Podium Presentation category is reserved exclusively for work that is being presented for the first time. Only truly original, practice-enhancing research, emerging data, or novel innovations that have not been presented, published, posted, or shared in any scientific, educational, or public forum are eligible.

To maintain the integrity of this high-visibility category and to respect the valuable time and expertise of our clinician reviewers, the following requirements will be enforced:

Submissions must represent new and unpublished work.

Content must not have been previously presented at any conference, symposium, webinar, event, etc.

Content must not have been published in any journal, digital platform, or similar outlet.

Submissions should include novel insights or innovative approaches with the potential to change or significantly enhance clinical practice.

Any submission entered in the First-to-Podium category that does not meet all eligibility criteria will be declined without an opportunity to resubmit. Our reviewers—who are clinicians volunteering their time and expertise—evaluate each submission with great care. We ask all submitters to adhere to these guidelines.

Embargo Note: Abstracts chosen by the Reviewer Committee for First-to-Podium presentation are embargoed until the start of the session in which they are featured, taking place on April 29, 2027.

2. Oral Presentation Only

The highest-scoring abstracts are eligible for oral presentations. Primary contacts/submitters will be notified about selection for an Oral Presentation by the acceptance deadline. Each presentation will be 10 minutes, including presentation time and Q&A. Oral presenters may also present their abstract as a poster in the Poster Hall.

3. Poster Presentation Only

Posters are displayed in the Poster Hall on bulletin boards 48 inches high by 96 inches wide. Printed posters will be available for viewing during all Poster Hall hours. ePosters (PDFs) will also be accessible through screens within the conference space and via the mobile app.

4. Poster Presentation If Not Selected for Oral Presentation Only

If your poster is not selected for podium presentation, for your abstract to still be considered for a poster presentation, choose the category "Poster Presentation If Not Selected for First-to-Podium or Oral."

5. RAPID-FIRE Poster Talks

Each presentation is 5 minutes, including Q&A. This session is for CE credit and requires additional paperwork to be completed. Commercial interests are not eligible to participate. The ACCME, ACPE, ANCC, and CPME define a “commercial interest” as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients, with these exemptions: nonprofit or governmental organizations and non-healthcare related companies.

Abstract Submission Categories

Submitted abstracts will be reviewed and scored based upon the review criteria specific to each submission category, as outlined here. Categories are as follows:

Case Series / Case Study
Clinical Research
Evidence-Based Practice
Health Economics
Laboratory Research
Practice Innovation

Abstract Submission Instructions

All abstracts must be submitted electronically via the official SAWC Spring | WHS 2027 abstract submission portal website. Paper or email abstract submissions will not be accepted.

View an in-depth overview of the Abstract Submission Guidelines here.

A link to submit your abstract will be available here starting Wednesday, September 16, 2026.

Embargo Policy for First-to-Podium Presentation Abstracts

All First-to-Podium Presentation abstracts will be published to the Wounds website, the official journal of the Symposium on Advanced Wound Care, following the meeting.

SAWC Spring | WHS Embargo Policy for First-to-Podium Presentation Abstracts

The Symposium on Advanced Wound Care (SAWC Spring | WHS) meeting follows a strict embargo policy to ensure the timely and accurate dissemination of scientific content. All abstract presenters, authors, Scientific Selection Committee and involved stakeholders must comply with the following guidelines to maintain the integrity of the conference and its communications.

1. Definition of "Embargoed" Content

"Embargoed content" refers to any abstract, research data, or findings presented at the SAWC Spring | WHS meeting that is identified as a First-to-Podium Presentation abstract. Such content is considered embargoed until the official embargo date is lifted by the meeting organizers.

2. Embargo Lift Date

Abstracts chosen by the Scientific Selection Committee for First-to-Podium presentation as part of the agenda/scientific program for the Symposium on Advanced Wound Care Spring | WHS are embargoed until the start of the session in which they are featured during the First-to-Podium Presentations on April 29, 2027. This means no data, findings, or abstract details can be shared publicly (through press releases, social media, media interviews, or other public channels) until after the first oral presentation of the abstract at the meeting.

3. Restrictions on Public Disclosure

Pre-Conference: Presenters and authors are prohibited from publicly sharing, presenting, or discussing abstract details, findings, or any related data prior to the official presentation at the SAWC Spring | WHS meeting.
Post-Conference: Once the embargo is lifted (i.e., after the official presentation), authors and presenters may publicly disclose their work but must ensure accurate representation of the information presented during the meeting.

4. Media and Press Engagements

Any media or press outreach regarding the content of First-to-Podium Presentation abstracts prior to the embargo lift date is strictly prohibited. All media representatives and journalists must adhere to this embargo policy.
If there is any interest in discussing research or preliminary findings with the media, authors must coordinate through the SAWC Spring | WHS Press office or communication channels to ensure compliance.
The embargo policy means that no news, information, results of any abstract, or research finding can be released to the media or published until the start of the session in which they are featured during the First to Podium Presentations on April 29, 2027. This embargo includes revealing anything about the results (including the title of the abstract, since frequently the title indicates the finding) in a press release or “curtain raiser.”

5. Consequences of Embargo Violations

Violation of the embargo policy will be taken seriously and may result in the withdrawal of the abstract from the conference or other sanctions, including disqualification from future participation in the conference.
Authors, presenters, associated colleagues, Scientific Selection Committee members, members of the press, and members of the healthcare or financial industry found in violation of the embargo may also face restrictions on presenting at subsequent SAWC or affiliated events.

6. Additional Guidelines

Authors as well as the Scientific Selection Committee should be aware that the embargo applies to all forms of public communication, including but not limited to social media posts, press releases, interviews, and publication in any media.
Presenters are encouraged to consult with the conference organizers or the press team if they have questions or need clarification about the embargo policy.

7. Press Information

For media and PR requests, visit our Press Page.

Notification and Terms of Acceptance

Correspondence

All abstract communications will be sent to the primary contact, who is the submitter. The primary contact is responsible for notifying all authors of important details and deadlines. Be sure to save the email address abstractsubmissions@hmpglobal.com to your address book so you don’t miss any important correspondence. Additionally, the website will be updated with important dates and instructions.

We are not responsible for any emails that are not received due to misspellings, defunct email accounts, or blocked emails from abstractsubmissions@hmpglobal.com.

Notification of Acceptance/Decline

Abstracts will be accepted on a competitive basis. The acceptance/decline notification email will be sent to the primary contact (submitter). Do not inquire about the status of your submission before the date noted at the top of this page, as no information will be available until that date. Prior to the meeting, all information will be forwarded to the primary contact only, and they are responsible for notifying all the authors of details.

Intent to Present

SAWC requires proof of conference registration for all accepted abstracts. After registering, it is the designated primary contact’s responsibility to mark his or her intent to present through the abstract portal, as outlined in the acceptance email. This includes providing the badge number of the registered representative, which can be found in the registration confirmation email. Instructions for this process will be included in the acceptance email. Even if you are registered for the meeting, you must still submit intent to present. If the intent to present is not submitted by the deadline listed in the acceptance email, the abstract will be withdrawn.

Expenses/Services

All expenses related to submitting and presenting an abstract, including travel, hotel, and conference registration, are the responsibility of the presenter.

Poster presenters are responsible for the cost and organization of printing, shipment, display of, and removal of printed posters in/from the Poster Hall during specified times. The conference does not provide these services.

Poster Setup/Display/Dismantling Information

View the schedule for poster setup, display, and dismantling here. Additional important information is below.

Posters are displayed on bulletin boards 48 inches high × 96 inches wide. The recommended print size is 40 inches high by 60 inches wide.

Push pins will be provided. If additional mounting supplies are needed, especially for heavier posters (laminated, vinyl, or other heavier material), bring these with you.

The distribution of product samples is prohibited.
Business cards may be distributed.

Handouts of the poster and QR codes linking to the poster may be pinned to the poster board. No other handouts or QR codes are permitted.

Audiovisual equipment will not be available for poster presentations.

At a minimum, all presenters need to be available to present their poster(s) during the Poster Reception.

Posters should not be removed prior to Poster Dismantling time. Any materials, including shipping tubes and/or posters, left in the poster hall will be discarded.

No-Show Policy

SAWC monitors all posters on site for non-attendance. Presenters who fail to appear without notification negatively impact the programming, create additional costs, and result in empty poster boards for attendees. Presenters who no-show without notice will not be eligible to submit abstracts to future SAWC meetings.

Withdrawals

Once an abstract is accepted, the submitter is obligated to ensure that it is presented by an author or appropriate representative. Formal withdrawals are accepted via email to abstractsubmissions@hmpglobal.com. Make sure to include the abstract title and first author’s name in your correspondence.

Failure to withdraw in writing and failure to present (no-show) will result in ineligibility for future SAWC abstract submissions as first author.

Important Links

Click below for information on:

Questions?

It is important to review the documents in the above Important Links section before contacting the SAWC Abstract Team with questions. If your questions are not answered in the above documents, email abstractsubmissions@hmpglobal.com.